Chronic Heart Failure: Current Evidence, Challenges to Therapy, and Future Directions

Author： Morrissey Ryan P. Czer Lawrence Shah Prediman K.

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.11, Iss.3, 2011-06, pp. : 153-171

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nebivolol in chronic heart failure: current evidence and future perspectives

By Lipšic Erik van Veldhuisen Dirk J

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 6, 2010-04 ,pp. : 983-992

Informa Healthcare

Access to resources Recommend Favorite

Future prospects of anticytokine therapy in chronic heart failure

By von Haehling Stephan Anker Stefan D

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 2, 2005-02 ,pp. : 163-176

Informa Healthcare

Access to resources Recommend Favorite

Endothelin Receptor Antagonists in Heart Failure: Current Status and Future Directions

By Ertl G. Bauersachs J.

Drugs, Vol. 64, Iss. 10, 2004-01 ,pp. : 1029-1040

Adis International

Access to resources Recommend Favorite

Molecular targeted therapy in recurrent glioblastoma: current challenges and future directions

By Patel Mital Vogelbaum Michael A Barnett Gene H Jalali Rakesh Ahluwalia Manmeet S

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 9, 2012-09 ,pp. : 1247-1266

Informa Healthcare

Access to resources Recommend Favorite

Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches

Current Pharmaceutical Design, Vol. 22, Iss. 31, 2016-09 ,pp. : 4807-4822

Bentham Science Publishers

Access to resources Recommend Favorite